Published In
Cerrahpaşa Medical Journal
Volume 49
Pages: 1-2
History
Published Online: March 27, 2025
Zeynep Altan Ferhatoğlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Tuğba Kevser Uzunçakmak
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Görkem Mutlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Altan Ferhatoğlu , Z., Uzunçakmak, T. K., & Mutlu, G. (2025). The Use of High-Dose Omalizumab in the Treatment of Resistant Chronic Urticaria: A Case Series. Cerrahpaşa Medical Journal, 49, 1–2. https://doi.org/10.5152/cjm.2025.25012
Full Text
Full Text PDF
Full Text PDF
Abstract
Cite this article as: Ferhatoğlu ZA, Uzunçakmak TK, Mutlu G. The use of high-dose omalizumab in the treatment of resistant chronic urticaria: a case series. Cerrahpaşa Med J. 2025, 49, 0012, doi: 10.5152/cjm.2025.25012
Article Info
Published In
Journal
Cerrahpaşa Medical Journal
Volume / Issue
Volume 49
Pages
1-2
History
Published Online
March 27, 2025
Affiliations
Zeynep Altan Ferhatoğlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Tuğba Kevser Uzunçakmak
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Görkem Mutlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
Cite this Article
Altan Ferhatoğlu , Z., Uzunçakmak, T. K., & Mutlu, G. (2025). The Use of High-Dose Omalizumab in the Treatment of Resistant Chronic Urticaria: A Case Series. Cerrahpaşa Medical Journal, 49, 1–2. https://doi.org/10.5152/cjm.2025.25012
Outlines